Contraceptive Dynamics in Rural Northern Malawi: A Prospective Longitudinal Study. by Dasgupta, Aisha Nandini Zoe et al.
Dasgupta, AN; Zaba, B; Crampin, AC (2015) Contraceptive Dynam-
ics in Rural Northern Malawi: A Prospective Longitudinal Study.
International perspectives on sexual and reproductive health, 41 (3).
pp. 145-54. ISSN 1944-0391 DOI: 10.1363/4114515
Downloaded from: http://researchonline.lshtm.ac.uk/2373902/
DOI: 10.1363/4114515
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
145Volume 41, Number 3, September 2015
Malawi is a poor country in Sub-Saharan Africa that has 
made attempts to address its population and fertility prob-
lems,1–5 by initiating programs to encourage birthspacing6 
and by organizing conferences on population and devel-
opment.1,7–9 Such activities may be showing some results. 
Malawi’s modern contraceptive prevalence rate (mCPR)—
the proportion of women of reproductive age who report 
that they (or their partner) are currently using a modern 
contraceptive—was six times as high in 2010 as it was in 
1992 (42% vs. 7%),10 a remarkable achievement and a 
higher level of use than in other countries in the region.11 
During that period, the percentage of married women us-
ing the injectable rose from 1.5% to nearly 26%.10
The mCPR is the most widely used measure of success 
of contraception programs.12,13 It is typically captured in 
Demographic and Health Surveys (DHS), the Multiple In-
dicator Cluster Survey and other large-scale national sur-
veys with the question “Are you currently doing something 
or using any method to delay or avoid getting pregnant?” 
If the reply is “yes,” the woman is asked what method she 
is using; nonmodern methods (e.g., withdrawal, the calen-
dar method) are excluded for calculation of mCPR.
Given Malawi’s high mCPR, the country has been her-
alded by the international community as a success story.14 
However, the country’s total fertility rate (TFR) has de-
creased only marginally, from 6.7 births per woman in 
1992 to 5.7 in 2010,10 and remains among the highest in 
the region.11 That Malawi’s greatly increased contraceptive 
use rate has not translated into notably lower fertility is 
surprising. Mozambique attained a similar TFR (5.9) in 
2011 with just 11% of women using modern contracep-
tives; likewise, Tanzania had a TFR of 5.8 in 1996, when its 
mCPR was only 13%.11
One explanation for Malawi’s fertility remaining high 
despite relatively high contraceptive use could be that al-
though mCPR is estimated cross-sectionally, the DHS uses 
births from the five years preceding the survey to calculate 
the TFR; thus, any increase in mCPR might not be reflected 
in the TFR until a few years later. Another possibility is an 
ecological analysis fallacy, in which contraceptive users 
might tend to be at low risk of pregnancy (e.g., women 
who are single, older or experiencing postpartum amenor-
rhea) and nonusers might contribute a disproportionately 
high number of births. Alternatively, proximate determi-
nants of fertility other than contraceptive use might play a 
significant role: for example, short breast-feeding periods 
and early age at sexual debut and marriage.
Another potential explanation is that fertility might be 
overreported. It is more likely, however, that contraceptive 
use is overreported. Women who have adopted the pill or 
the injectable might consider themselves contraceptive 
users and report themselves as such, even though they 
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17 countries studied, Malawi had the lowest proportion 
of women who reported switching to another modern 
method within three months of method-related discon-
tinuation, which suggests poor switching behavior in the 
context of discontinuation.
We conducted a prospective study that used an innova-
tive method for collecting data on contraception: Patient-
held records of provider-recorded service information were 
used to build a longitudinal data set that allowed the ex-
ploration of continuity of use and method switching. Indi-
vidual records were linked to a demographic surveillance 
site through a unique identifier system. This was done to 
help shed light on contraceptive use, discontinuation and 
switching, and to explore how these behaviors relate to fer-
tility in Malawi.
METHODS
Data
The Karonga Prevention Study (KPS) operates a health 
and demographic surveillance site in rural northern Ma-
lawi that included 36,524 individuals in 8,076 households 
at the end of 2012.21 Other recent demographic surveil-
lance site studies have focused on adult HIV, sexual and 
reproductive behavior and fertility intentions.18,22–24 The 
KPS used cross-sectional data from 2008–2009 and ques-
tions similar to those in the DHS, and estimated the mCPR 
among married women to be 45%,18 which is the same as 
that for Karonga district in the 2010 DHS.10 A range of con-
traceptive methods is available in the study area from gov-
ernment, Christian Health Association of Malawi, nongov-
ernmental organization (NGO) and private facilities,25,26 as 
well as at the community level, from such sources as gov-
ernment outreach posts and providers’ or clients’ homes. 
There are also various types of service providers, including 
clinical officers, nurses, medical assistants, health surveil-
lance assistants (some of whom are trained to provide the 
three-month injectable) and community-based distribu-
tion agents (volunteers who may provide two cycles of oral 
contraceptives at a time, and condoms).27–29
Between January and April 2012, family planning cards 
were offered to all 7,393 women aged 15–49 living in the 
KPS demographic surveillance site. Cards were attached 
to women’s health passport (i.e., patient-held medical re-
cord); women were asked to keep the card for one year. To 
allow rapid distribution of cards, KPS fieldworkers trained 
278 local key informants (who make monthly reports to 
KPS of all births and deaths in the site) to issue the cards 
using project-generated listings of eligible women.
All 132 health care providers working in the study area 
were trained to record information on women’s cards 
whenever they provided women with contraceptives; mul-
tiple refresher trainings were conducted. Providers were 
given free mobile phone airtime, and periodically received 
motivational text messages to encourage them to continue 
recording data on cards. The task was formally designated 
by the district family planning coordinator as part of pro-
viders’ record-keeping responsibilities.
missed their last appointment to pick up a new supply of 
pills or get their next injection, and so technically are not 
current users. There could be something different about 
provision of contraception services in Malawi (e.g., more 
common stockouts) that means women there are more 
likely than women in other countries to miss reinjection 
or resupply appointments and, thus, overreport their con-
traceptive use. The mCPR, which tends toward a measure 
of period prevalence rather than point prevalence, might 
fail to capture these gaps; long-term inconsistent use of 
short-term methods amplifies this issue. Moreover, Mala-
wian women may give what they perceive to be the desired 
response, as a result of exposure to media campaigns and 
multiple provider-initiated family planning conversations.
One way of assessing the quality of contraceptive data is 
to compare linked husband and wife reports, and identify 
any discrepancies.15,16 Typically, husbands report higher 
levels of contraceptive use than their wives.16 In addition, 
findings from Malawi suggest that when couples give dis-
cordant responses to survey questions (e.g., on ownership 
of household items, use of family planning), generally 
the husband responds “yes” and the wife “no.”17 Another 
study found better agreement on contraceptive use among 
monogamous couples than among those in polygamous 
unions.18 Underreporting and overreporting can occur 
simultaneously, and in the Malawi context, overreporting 
could possibly be more common. According to the Malawi 
DHS, only 5% of contraceptive users have not told their 
husband that they are using contraceptives;10 this suggests 
that the users may be unlikely to underreport use to an 
independent interviewer.
Another explanation could be inconsistent use of con-
traceptives. In their seminal paper, Curtis and Blanc argue 
that it is important to examine such contraceptive dynam-
ics as switching and discontinuation because, as desired 
family size declines and contraceptive prevalence increas-
es, effectiveness and duration of use become increasingly 
significant determinants of total fertility, unintended preg-
nancies and induced abortions.19 In our article, consistent 
contraceptive use refers to continuous use with no breaks; 
it can include method switching, as long as there are no 
gaps in use.
Information on family planning comes from a variety 
of sources, such as routine health facility records and ret-
rospective surveys. The contraceptive calendar developed 
by the DHS captures a woman’s retrospective self-reported 
contraceptive status and method every calendar month 
for the five years prior to interview. Retrospective contra-
ceptive calendars are prone to selection bias, because only 
those surviving to interview can report. In addition, it can 
be difficult for many women to recall their contraceptive 
use or interruptions in use for as long as five years. Yet, 
with the exception of the calendar method, assessments 
of contraceptive use do not attempt to capture method 
switching or discontinuation. Using 2004 DHS calendar 
data, Ali and colleagues found high contraceptive dis-
continuation rates in Malawi.20 They also found that of 
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facility or, at the community level, a health surveillance as-
sistant or community-based distribution agent).
Our data collection method correctly identified all 
women who had reported in three previous KPS surveys 
that they had had a tubal ligation. In cases in which the 
supply date of contraceptive services was not reported, we 
imputed it on the basis of supply dates of other services 
the woman received, and the date she received and submit-
ted her card.
At the time their family planning card was collected, 
women were asked to report on condom use during the 
study period; however, we made no systematic attempt 
to get dates for when women purchased or obtained 
condoms. Condoms are generally considered to be for 
HIV prevention rather than contraception, but are often 
used for dual protection.32 In addition, condoms can be 
obtained by women’s partners (which would not be re-
corded on cards) and used later rather than at the time of 
purchase. Moreover, they tend to be used inconsistently,33 
either to a different extent with different partners or only 
when HIV or other STIs are present.34 Therefore, we did 
Between February and May 2013, a year after the fam-
ily planning cards were distributed, the KPS field team 
collected the cards from women at designated meeting 
points in the community, and checked the cards against 
health passport entries to ensure that all family planning 
episodes were noted on cards. In addition, women were 
asked to give a verbal report of their family planning use 
over the previous year at the time that their card was col-
lected. Team members recorded any missing family plan-
ning episodes onto the card, and noted the source of the 
information (health passport or women’s self-report). 
Thus, the majority of data were entered by health care pro-
viders at the time of service, but gaps in data were filled 
retrospectively by women’s recollections to allow a more 
complete and accurate data set than would be possible 
with conventional methods. Women who had had a tubal 
ligation or had received an implant or IUD prior to receiv-
ing a family planning card had this recorded on their card, 
which explained why their card was blank when collected.
Ethical approval for the study was granted by the Col-
lege of Medicine Research and Ethics Committee, Malawi, 
and the ethics committee at the London School of Hygiene 
and Tropical Medicine. Informed written consent for the 
collection and analysis of data was obtained from the 
study participants upon collection of the family planning 
cards. More detailed methods and an evaluation of the suc-
cess of the data collection are described elsewhere.30
Data Management and Analytic Approach
We used identifying information on women to link their 
family planning card data to their data in the existing KPS 
database. Stata 12 was used for all analyses.
We used birth dates from demographic surveillance 
site records to calculate women’s age when they received 
their card, and obtained their highest level of education 
from previous KPS socioeconomic surveys. HIV status 
had been collected as part of previous KPS studies that 
included door-to-door HIV testing with rapid tests. We 
assumed that women were HIV negative if they had had 
a negative test result less than four years before receiving 
the card (HIV incidence in the area is less than 0.1% per 
annum31), and HIV positive if they had received a posi-
tive result at any time before receiving the card; the HIV 
status for all other women was unknown. For other time- 
varying covariates (marital status and fertility intention, 
both collected as part of a 2010–2011 adult sexual behav-
ior survey), we used the most recent observation within 
two years of receiving the card; those who did not have 
an observation within that time frame were considered to 
have missing data. Eighty-five percent and 45% of women 
had an observation for marital status and fertility inten-
tions, respectively, recorded within one year before they 
received a card. Because GPS coordinates are available for 
all residents (including community health care workers) in 
the demographic surveillance site, we were able to calcu-
late distances from women’s residences to the closest road 
and the closest provider of family planning (i.e., a health 
TABLE 1. Percentage distribution of all eligible women, and percentage distribution 
of study participants, by contraceptive use, Karonga Prevention Study, Malawi, 2012
Characteristic All eligible 
women
Participants
All Contraceptive 
users
Contraceptive 
nonusers†
Marital status*** (N=7,362) (N=4,593) (N=1,981) (N=2,612)
Currently married 66.9 73.3 86.1 63.6
Separated/widowed/
divorced 13.5 13.2 11.1 14.9
Never married 19.6 13.5 2.8 21.6
Proximity to road** (N=7,388) (N=4,602) (N=1,984) (N=2,618)
<1km 47.9 44.3 46.7 42.5
>1km 52.1 55.7 53.3 57.5
Proximity to family
planning provider*** (N=7,388) (N=4,595) (N=1,987) (N=2,608)
<0.5km 39.1 39.5 42.6 37.2
0.5–1.5km 54.7 54.0 52.0 55.6
>1.5km 6.2 6.4 5.4 7.2
Education** (N=7,379) (N=4,598) (N=1,983) (N=2,615)
Incomplete primary 7.4 7.6 6.3 8.6
Complete primary 57.0 61.4 63.3 60.0
≥secondary 35.6 30.9 30.4 31.4
HIV status (N=6,396) (N=4075) (N=1,837) (N=2,238)
Positive 8.9 9.0 8.4 9.4
Negative 91.1 91.0 91.6 90.6
Parity*** (N=5,416) (N=3,747) (N=1903) (N=1,844)
0 3.4 2.7 2.9 2.5
1–4 61.5 58.8 61.6 55.9
≥5 35.2 38.5 35.5 41.6
Fertility intention*** (N=5,013) (N=3,361) (N=1,525) (N=1,836)
No more children 42.1 45.7 53.5 39.3
Wait ≥2 years 37.8 35.6 35.0 36.1
Want within two years 12.7 12.7 8.4 16.3
Unsure 7.4 6.0 3.1 8.3
Total 100.0 100.0 100.0 100.0
**Difference between contraceptive users and nonusers significant at p<.01. ***Difference between con-
traceptive users and nonusers significant at p<.001. †Includes users of condoms (male and female) and 
traditional methods.
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ter they received a family planning card, on the basis of 
service provision dates. Retrospective verbal reports of the 
injectable and the pill were excluded, as they are likely to 
be overreported.
According to the manufacturer’s guidelines, the three-
month injectable must be resupplied within 13 weeks; 
however, according to WHO guidelines, if the woman 
has not yet menstruated, it is acceptable to give her the 
follow-up injection up to 17 weeks. Therefore, we calcu-
lated the CPP using three assumptions for how long the 
injectable protects a woman against pregnancy (13, 17 and 
21 weeks). This demonstrates the impact on the mCPR of 
different assumptions of injection duration.
In addition, we examined women’s adherence to the 
three-month injectable, because of the Malawi family plan-
ning program’s focus on this method for contraception. 
Event-history analysis was used to explore contraceptive 
discontinuation.
RESULTS
Descriptive Findings
Of the 7,393 eligible women, 6,861 (93%) were issued a 
family planning card and 4,678 (63%) submitted their 
card after one year; participants’ mean age was 30.4 years, 
and the average observation time was 383 days (range, 
122–519; standard deviation, 38). Nonparticipants were 
slightly younger, were more likely to be never married 
and were more educated than women who participated.30 
Overall, 43% of participants used a modern method of 
contraception (excluding condoms) at some point during 
the study period. Among those using contraceptives dur-
ing the study year, 86% were currently married and only 
3% were never married (Table 1, page 147). Contraceptive 
users were more likely than nonusers to be currently mar-
ried, live close to a road and to a family planning provider, 
have achieved a higher level of education and want no 
more children; in addition, contraceptive users were older 
(not shown).
Methods that require repeat visits accounted for the 
most provider-client contacts over the study period, with 
visits for the injectable making up the great majority (79%; 
Table 2). Community-level providers were involved in 
more than three-quarters of contacts (health surveillance 
assistants in 66% and community-based delivery agents in 
11%). And although a notable proportion of contacts oc-
curred at government health facilities, six in 10 occurred 
outside of facilities at outreach posts (14%), providers’ 
homes (37%) or clients’ homes (7%).
Contraceptive Point Prevalence
CPP rose slightly with increased time since receiving a fam-
ily planning card (Table 3): For example, assuming that 
the injectable lasts 13 weeks, the CPP for married women 
was 33% at five months, 35% at seven months and 36% 
at nine months. This suggests that some of the early inject-
able provisions may have been missed as the study was 
being rolled out or that contraceptive uptake was actually 
not conduct event-history analyses of condom use. Infor-
mation on ever-use of traditional methods (withdrawal 
and the calendar method) was obtained from women at 
the time their card was collected, but was not subject to 
event-history analysis.
Because of the predominance of short-term methods in 
Malawi, we needed a measure that would allow a precise 
estimation of the proportion of women actually protect-
ed by a modern contraceptive method on a specific day, 
taking into account discontinuation and gaps in use. We 
therefore developed a new measure, contraceptive point 
prevalence (CPP). In this article, we calculate the CPP at 
three points in time, using the provider-recorded prospec-
tive data collected on patient-held records. To investigate 
the consistency of the CPP, we estimated it for married 
women and all women at five, seven and nine months af-
TABLE 3. Proportion of married women and all women currently using a modern 
method of contraception, as per provider-recorded data (contraceptive point preva-
lence), by number of months since women received a family planning card, according 
to assumed duration of injectable
No. of mos. since receiving 
family planning card
Assume injectable lasts for
13 weeks 17 weeks 21 weeks
Married 
women
All  
women
Married 
women
All 
women
Married 
women
All 
women
5 33.4 28.0 35.0 29.3 36.0 30.2
7 35.1 29.5 36.9 30.9 37.8 31.7
9 35.6 30.5 37.2 31.8 38.4 32.7
Note: Excludes condoms (male and female).
TABLE 2. Percentage distribution of provider-client con-
tacts for contraception during the study period, by method 
type, provider type and location where contraceptive ser-
vices were provided
Detail %
Method type† (N=3,281)
Tubal ligation 1.7
Implant 5.6
IUD 0.0‡
Injectable 79.0
Pill 13.4
Removal of implant/IUD 0.3
Provider type (N=3,142)
Clinical officer 5.2
Medical assistant 1.4
Nurse 16.6
Health surveillance assistant 65.8
CBDA 11.0
Youth CBDA 0.2
Location (N=3,251)
Government facility 37.1
CHAM facility 3.4
NGO/private facility 1.4
Outreach post 14.1
Provider’s home 36.8
Woman’s home 7.0
Other 0.2
Total 100.0
†Excludes condoms (male and female) and traditional methods. Notes: 
CBDA=Community-based distribution agent. CHAM=Christian Health 
Association of Malawi. ‡One contact was for IUD use.
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the family planning card data estimate of implant use was 
higher than other estimates (7% vs. 1–3%), but this may 
have been because card data were collected in 2012–2013 
(rather than 2010 for the other data), after a general im-
increasing. Similarly, CPP increased with increased inject-
able duration. For example, the CPP for married women 
seven months after receiving a card was 35% assuming 
injections last 13 weeks, 37% if they last 17 weeks, and 
38% if they last 21 weeks. This demonstrates that mCPR 
could be overestimated if women are late for reinjection 
(and thus technically are no longer contraceptive users), 
yet continue to consider and report themselves to be con-
traceptive users.
We compared CPP (at seven months and assuming that 
an injection lasts 13 weeks) and method mix for currently 
married women derived from family planning card data 
with cross-sectional mCPR data from a 2010–2011 KPS 
sexual behavior population survey, and with national and 
district-level cross-sectional mCPR data from the 2010 
Malawi DHS (Table 4). The proportion of injectable use 
in the method mix estimated from card data (14%) was 
noticeably lower than other estimates (20–26%), which 
suggests that conventional cross-sectional data may over-
estimate point prevalence use of injectables. In addition, 
TABLE 4. Percentage distribution of currently married women, by contraceptive 
method currently used, according to survey
Method KPS estimate of 
CPP, 2012–2013†
KPS estimate 
of mCPR, 
2010–2011‡
mCPR estimate,  DHS, 2010
Karonga National
Total mCPR or CPP 35.1 46.2 45.4 42.2
Tubal ligation 12.8 10.5 12.1 9.7
Vasectomy na 0.0 0.0 0.1
Implant 6.8 2.9 3.2 1.3
IUD 0.3 0.0 0.0 0.3
Injectable 14.1 21.1 19.9 25.8
Pill 1.2 1.7 1.3 2.5
Condom na 10.0 8.8 2.5
†At seven months since receiving family planning card, assuming injections protect against pregnan-
cy for 13 weeks. ‡From third round of adult sexual behaviour survey, Karonga Prevention Study. Notes: 
CPP=contraceptive point prevalence. DHS=Demographic and Health Survey. na=not available.
0
.2
5
.5
.7
5
1
0 100 200 300 400
FIGURE 1. Probabilities of receiving a follow-up contraceptive injection
0
.2
5
.5
.7
5
1
0 100 200 300 400
Days since ﬁrst injection
Probability of receiving follow-up injection
0
.2
5
.5
.7
5
1
0 100 200 300 400
a. Probability of receiving follow-up injection
0 100 200 300 400 
  Days since first injection
805 622 400 132 0 
Number at risk
291 114 4 0 0 
Number at risk
    0
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
 1
 0 
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
  1
  
  0
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
1
0 100 200 300 400 
  Days since second injection
0 100 200 300 400 
  Days since third injection
Note: Vertical lines indicate 91 days, the time by which WHO guidelines state the next injection must be administered.
c. Probability of receiving third injection after second injection d. Probability of receiving fourth injection after third injection
522 367 122 1 0 
Number at risk
0.
25
0.
50
0.
75
1.
00
0 100 200 300 400
Days since ﬁrst injection
No Yes
Probability of receiving follow-up injection by condom useb. Probability of receiving follow-up injection, by condom use
111 74 43 21 0 
Number at risk
0 100 200 300 400
  Days since first injection  
 No use Use
   0
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
 1
Contraceptive Dynamics in Rural Northern Malawi
International Perspectives on Sexual and Reproductive Health150
HIV status (not shown). In contrast, women who reported 
condom use during the study year were less likely than 
those who did not to have received their second injection 
on time (Figure 1b, page 149).
Fifty-three percent of women received their third injec-
tion on schedule after their second, and 65% received their 
fourth injection on schedule after their third (Figures 1c 
and 1d, page 149). The proportion receiving a reinjection 
on time improves with each additional injection, presum-
ably because women who persevere with the method are a 
selected group of committed users or have fewer barriers 
to use. Only 15% of women who had at least one injection 
managed to adhere to the method for a whole year without 
experiencing a gap between injections of greater than 13 
weeks (not shown), which demonstrates very high discon-
tinuation.
•Oral contraceptives. Typically, providers supply women 
with two cycles (56 days) of oral contraceptives at each 
contact. Whereas the injectable may offer some protection 
against pregnancy beyond its recommended duration, 
a woman is no longer protected once she has run out of 
pills. Only 28% of women who initially received the pill 
had gotten a resupply within 56 days (Figure 2a). No vari-
ables associated with pill discontinuation were identified, 
although this may, in part, be because of the small sample 
of pill users (and the correspondingly wide confidence in-
tervals). Women’s probability of either continuing with the 
pill or switching to another modern method (excluding 
condoms) within 56 days was 35% (Figure 2b).
Method Switching
Over the one-year study period, the maximum number 
of methods (excluding condoms) used by an individual 
woman was two, even among women who saw provid-
ers many times (not shown). Just 84 contraceptive users 
(4%) switched methods. Switchers tended to be younger, 
because older women are more likely to use long-acting 
plant promotion in Malawi.
The family planning card data did not capture vasec-
tomy or condom use, so the total CPP estimate (35%) 
should be compared with the other mCPR estimates after 
subtracting condom and vasectomy use (36–40%); vasec-
tomies are extremely rare in Malawi, and condom use is 
likely to be overestimated in conventional cross-sectional 
estimates, because of inconsistent use.
Method Adherence
•Injectable. Just 51% of women had a follow-up injection 
within 13 weeks of their first, and only 69% received a 
follow-up injection within a year (Figure 1a, page 149); 
these results were not affected by exclusion of imputed 
dates. Seven percent of women received their second injec-
tion within 11 weeks, which is technically too early, is a 
waste of program resources and may increase side effects. 
On-schedule reinjection was not associated with women’s 
age, parity, education, proximity to a road, proximity to a 
health care provider, fertility intentions, marital status or 
FIGURE 2. Probabilities of receiving resupply of oral contraceptives and of continuing use of a contraceptive method after 
oral contraceptive use
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2b. Probability of continuing with any contraceptive ethod
TABLE 5. Descriptive statistics of method switching
Statistic First method used
Tubal ligation Implant IUD Injectable Pill
Total no. of women  
starting method
49 147 1 956 125
% using exclusively 100 98 100 95 82
% ever-used other methods
Tubal ligation na 0 0 0 1
Implant 0 na 0 3 3
IUD 0 0 na 0 0
Injectable 0 2 0 na 14
Pill 0 0 0 2 na
Total no. of methods reported 49 150 1 1,006 148
Index of changeability† 1.00 1.02 1.00 1.05 1.18
†Index of changeability is the average number of methods a woman used. It is the ratio of the total num-
ber of methods by total number of women. Notes: na=not applicable.
Note: Vertical lines indicate 56 days, as two 28-day cycles of pills are typically provided to women at each contact. 
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tives continuously may not need to target any specific sub-
groups, but instead should target all short-term method 
users. Similarly, Ali and Cleland found that education had 
little effect on method discontinuation, although it had an 
effect on method switching.35 We are not aware of major 
stockouts of the injectable in the area during the study 
period that could explain the lack of association between 
women’s characteristics and adherence; however, some pe-
riodic stockouts of the pill did occur, and these may have 
masked differences in women’s characteristics.
Few women switched methods over the study period. 
This may have been a result of the relatively short follow-
up time; however, according to a study by Ali et al., women 
who did not switch within three months of discontinua-
tion were unlikely to switch thereafter.20 That study also 
showed that fewer women in Malawi than in any other 
country examined switched methods within three months 
of discontinuation. Thus, our findings of low method 
switching support those of Ali et al.
Contraceptive injections accounted for most of women’s 
contacts with providers and were generally administered 
at outreach clinics or at providers’ or women’s homes by 
low-cadre health care providers. This finding demonstrates 
the importance of community-based distribution of short-
term contraceptive methods by well-trained, lower-cadre 
staff. Strategies to improve this model could be explored, 
with the goal of helping women use contraceptives con-
tinuously without gaps; however, there is weak evidence 
that discontinuation can be reduced by higher quality 
services.20 A systematic review of randomized controlled 
trials of intensive counseling techniques versus routine 
family planning counseling found no benefit of counseling 
strategies to improve adherence and continuation.36 Else-
where, it has been argued that underlying motivation to 
avoid pregnancy is an important factor in discontinuation, 
putting the onus on the woman.37 Reasons for contracep-
tive discontinuation under different circumstances need to 
be better understood.
Nevertheless, the provision of services could be 
strengthened in other ways. For example, procurement 
systems could be improved to reduce stockouts, and clinic 
hours could be increased and confidentiality of services 
could be ensured to try to reduce discontinuation. Health 
care providers should be retrained to counsel women on 
the importance of presenting on time for repeat visits and 
to assist women dissatisfied with their method in iden-
tifying an alternative, so that they can switch methods 
rather than discontinue use altogether. Further innova-
tive counseling tools are being developed that incorporate 
theories of behavior with reproductive and sexual health 
practice,38,39 but require evaluation, particularly for their 
impact on continuity of use.
The method mix was skewed in favor of the injectable 
and tubal ligation (for women who had completed child-
bearing), which might reflect cultural preferences and so-
cial norms; however, it would be problematic if the reason 
was a lack of access to alternative methods or provider 
methods. Women wanting no more children tended not 
to switch methods, again because they are more likely 
than women who want more children to use permanent 
methods. Marital status, education and parity were not as-
sociated with switching. Among contraceptive users who 
used only one method during the year, 15% also reported 
condom use, which did not differ significantly from the 
proportion among women who switched methods (11%). 
Among women who did not use tubal ligation, the im-
plant, the IUD, injectable or the pill during the study, 28% 
reported using condoms and 19% traditional methods.
Table 5 (page 150) presents ever-use of contraceptive 
methods during the study period by the first method 
women were recorded as using during the study period. 
For example, 147 women were recorded as first using 
the implant; of those, 98% used the implant exclusively 
throughout the study period, and 2% switched to the in-
jectable. None of the 49 women who were first recorded 
using tubal ligation used any other method.
We include an index of changeability, which indicates 
the average number of methods women used during the 
study period and was calculated by dividing the total num-
ber of methods used by the total number of women first 
recorded as using a specified method by the total number 
of women first recorded using that method. For women 
who were first recorded using the pill, the index of change-
ability score was 1.18, which represents a notable rate of 
switching (predominantly to the injectable). The index 
scores for women first recorded using the injectable and 
implant were low (1.05 and 1.02, respectively); those who 
did switch from the injectable changed to the implant and 
the pill, and those who switched from the implant changed 
to the injectable.
DISCUSSION
The prospective longitudinal data set that we generated 
from patient-held records offers unique insight into con-
traceptive dynamics among reproductive-age women liv-
ing in a demographic surveillance site in rural northern 
Malawi. Key findings of our analyses of these data include 
very high discontinuation rates of the injectable and the 
pill, which indicates irregular use of short-term methods 
that leave women exposed to the risk of pregnancy.
A number of characteristics were associated with ever-
use of modern contraceptives over the study year. Com-
pared to nonusers, contraceptive users were older and 
more likely to be currently married, live close to a road and 
to a family planning provider, have achieved a higher level 
of education and want no more children. However, none 
of the variables studied were associated with continuity of 
use, although those who discontinued injectable use were 
more likely than those who did not to have used condoms 
during the study period, presumably a consequence rath-
er than a cause of injection discontinuation. This finding 
demonstrates that no group of women was better than an-
other at adhering to short-term contraceptive use. Thus, 
interventions that aim to help women to use contracep-
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new health passports in Malawi have a family planning 
section akin to the family planning card, which allows 
for the recording of injectable or pill provision. If service 
providers were trained to correctly fill out this page and 
techniques were implemented to promote their doing so 
(e.g., text message reminders and financial incentives), a 
periodic sampling of health passports would provide lon-
gitudinal contraceptive data for switching and discontinu-
ation analyses. The page should also more clearly allow for 
a woman to switch methods, as it tends to be used only for 
either the pill or the injectable.
Although the study took place in a small area of rural 
northern Malawi, we believe the findings are likely to be 
generalizable to other parts of Malawi and Sub-Saharan 
Africa, given that the challenges around contraceptive use, 
discontinuation and persistently high fertility are likely to 
be similar.
Conclusions
Our findings have implications for how conventional 
mCPR estimates are interpreted, and how to quantify the 
size of the overestimate. We suggest adding probes to con-
ventional cross-sectional enquiries to ascertain whether 
women are using a method continuouslyk and whether 
they are currently protected. For example, in addition to 
the existing question “Since what month and year have you 
been using (current method) without stopping?” women 
using the injectable should also be asked “What date did 
you last have your injection?” to cross-check whether 
it was within the last three months; a similar enquiry is 
needed for pill supplies. These additional questions would 
validate the enquiry on current use of contraception; how-
ever, additional questions have time and cost implications 
for already-lengthy questionnaires. Alternatively, others 
have suggested weighting prevalence by method-specific 
effectiveness or continuation rates, to account for the vaga-
ries of typical use without additional survey questions.44,45
That conventional estimates of mCPR may overesti-
mate the true contraceptive point prevalence—particularly 
in contexts with dependence on short-term methods—is 
likely to be a contributing factor to the disconnect between 
self-reported contraceptive use and fertility.
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contraceptive moderne (TPCm) communément utilisé comme 
le meilleur indicateur de performance du programme de pla-
nification familiale. 
Méthodes: Un ensemble de données longitudinal prospec-
tif sur une année a été créé au départ de cartes-patientes de 
planification familiale de 4 678 femmes en âge de procréer 
résidentes d’un site de surveillance démographique dans le 
nord rural du Malawi. Les données de services contraceptifs 
enregistrées par les prestataires sur les cartes des femmes ont 
été liées à leurs données démographiques et de santé. Les esti-
mations de prévalence ponctuelle de la contraception calculées 
sur la base de ces données ont été comparées aux estimations 
du TPCm issues d’enquêtes transversales. L’observance contra-
ceptive est examinée par analyses de survie. 
Résultats: À 35%, la prévalence ponctuelle de la contracep-
tion s’est révélée légèrement inférieure aux estimations trans-
versales comparables du TPCm. Parmi les utilisatrices de 
l’injectable—la méthode moderne la plus répandue —51% seu-
lement avaient reçu une nouvelle injection à temps et 15% à 
peine avaient observé la méthode pendant 12 mois. Plusieurs 
variables ont été associées à la pratique contraceptive, mais 
aucune à l’observance. 
Conclusions: Les interruptions d’usage et abandons de 
l’injectable jouent peut-être un rôle dans la divergence obser-
vée entre le TPCm et la fécondité. Les interventions propices 
à l’observance de l’injectable et à la promotion des méthodes 
longue durée doivent être renforcées. 
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a aclarar este enigma y a determinar si la comúnmente usa-
da tasa de prevalencia de uso de anticonceptivos modernos 
(TPAm) es el mejor indicador del desempeño de programas de 
planificación familiar.
Métodos: Se creó un conjunto prospectivo de datos longitu-
dinales de un año a partir de tarjetas de registro conservadas 
por 4,678 pacientes mujeres en edad reproductiva que viven en 
un área de vigilancia demográfica en la región rural del norte 
de Malaui. Los datos de servicios anticonceptivos registrados 
por los proveedores de servicios en las tarjetas de las mujeres 
fueron vinculados con sus datos demográficos y de salud. Las 
estimaciones relativas a la prevalencia puntual de uso de an-
ticonceptivos calculadas a partir de estos datos se compararon 
con estimaciones de TPAm provenientes de encuestas transver-
sales. La adherencia a los anticonceptivos se examinó median-
te análisis de supervivencia.
Resultados: La prevalencia puntual de uso de anticonceptivos 
del 35% fue ligeramente menor que las estimaciones transversa-
les comparables de TPAm. Solamente el 51% de las usuarias de 
inyectables —el método moderno más usado— recibió la siguien-
te inyección a tiempo, y solo el 15% se adhirió al método por 12 
meses. Aunque diversas variables del estudio se asociaron con 
el uso de anticonceptivos, ninguna se asoció con la adherencia. 
Conclusiones: La interrupción y la discontinuación del uso 
de los inyectables pueden influir en la discrepancia entre la 
TPAm y la fecundidad. Deben fortalecerse las intervenciones 
para ayudar en la adherencia de las mujeres al uso de inyecta-
bles y para promover los métodos de larga duración. 
RÉSUMÉ
Contexte: La pratique accrue de la contraception au Malawi 
n’a pas donné lieu à une réduction correspondante de la fécon-
dité, mais la raison en est inconnue. Un regard sur les chan-
gements de méthode et l’arrêt de la contraception pourrait 
éclairer l’énigme et la validité ou non du taux de prévalence 
